Categories: Business

NYSE Content Advisory: Pre-market update + Ambiq raises $96 million in IPO

NEW YORK, July 30, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on July 30th

- Advertisement -
  • Equities are little changed early Wednesday after a delayed trade deal with China took the S&P 500 three tenths of a percent from its record. It was the first session of the last seven that the index didn’t finish at an all-time high.
  • This afternoon, Americans will receive the Federal Reserve’s decision on interest rates. The market is nearly certain rates will remain unchanged despite pressure from the White House to lower them.
  • Chipmaker Ambiq debuts at the NYSE today after raising $96 million in its IPO. Shares priced at $24 in an upsized deal. Ambiq will trade under the ticker symbol AMBQ.

Opening Bell
Ambiq Micro (NYSE: AMBQ) celebrates its initial public offering

- Advertisement -

Closing Bell
Morgan Stanley (NYSE: MS) celebrates the launch of their new Power E*TRADE platform

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2741064/NYSE_Market_Update_July_30.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5437855/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–ambiq-raises-96-million-in-ipo-302517389.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 weeks ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

3 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 months ago